redirecting t-cell cytotoxicity and proliferation
Published 5 years ago • 70 plays • Length 2:18Download video MP4
Download video MP3
Similar videos
-
2:41
cell avidity as a predictor of t-cell efficacy
-
2:48
the novel icaht grading system to predict toxicity following car t-cell therapy
-
3:14
using machine learning to identify trajectories of hematotoxicity following car t-cell therapy
-
2:16
phase i study of donor-derived γδ t cells as relapse prophylaxis post haplo/cy
-
25:47
[nataliya prokhnevska] cd8 t cell activation in cancer
-
6:28
cytoquest™ cr ctc enrichment - rbc lysis
-
9:25
mgus diagnosis: a step-by-step approach
-
0:37
the mechanism of treatment resistance in aml: do cd8-expressing t-cells become exhausted?
-
1:47
identifying positive regulators of t cell functions to improve cellular therapies
-
3:27
the mechanism of bispecific t-cell engagers in b-all: genomic alterations
-
1:02
the use of car-t cell products in a real-world setting
-
0:43
developing an avidcar platform to improve t-cell activity
-
2:12
addressing issues with t-cell therapies for hematologic malignancies
-
2:14
long-term follow-up results from the rathl trial: response-adapted treatment for advanced stage hl
-
3:08
welcome to the video journal of hematology & hematological oncology 🎥🩸
-
8:57
outcomes of sct in t-all and t-lbl
-
2:16
determining when to switch from hydroxyurea to interferon-based therapy in patients with pv
-
2:00
the role of fedratinib in 2024 and beyond
-
5:35
clinical and prognostic significance of aberrant t-cell marker expression in aml
-
3:51
skewed primary antigen-specific responses and chromatin remodelling of t-cells
-
2:44
do biomarkers exist for predicting response to car t-cell therapy?